BCAL Diagnostics Ltd
BDX
Company Profile
Business description
BCAL Diagnostics Ltd is a biotechnology company developing a novel blood screening test to improve the early diagnosis and monitoring of breast cancer by identifying, measuring, and validating specific biomarkers enriched from patient's blood. The BCAL technology utilizes a single blood test on multiple levels including disease detection, diagnostic mass screening, and post-intervention.
Contact
Queen Victoria Building
GPO Box Q128
SydneyNSW1230
AUSSector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,704.40 | 180.10 | 2.39% |
| CAC 40 | 7,172.82 | 245.70 | 3.55% |
| DAX 40 | 20,453.34 | 663.72 | 3.35% |
| Dow JONES (US) | 39,394.56 | 1,428.96 | 3.76% |
| FTSE 100 | 7,969.98 | 267.90 | 3.48% |
| HKSE | 20,127.68 | 299.38 | 1.51% |
| NASDAQ | 16,300.51 | 697.25 | 4.47% |
| Nikkei 225 | 33,012.58 | 1,876.00 | 6.03% |
| NZX 50 Index | 11,891.44 | 115.56 | 0.98% |
| S&P 500 | 5,261.82 | 199.57 | 3.94% |
| S&P/ASX 200 | 7,510.00 | 166.70 | 2.27% |
| SSE Composite Index | 3,145.55 | 48.97 | 1.58% |